[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6586 

# __Potential failure of vaccine efficacy in later clinical trials__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Conduct thorough pre-clinical testing, closely monitor adverse effects, and continue to improve vaccine design](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8460.md)

## Name of the risk

Delay in vaccine development and population immunity, leading to prolonged spread of the disease

## People affected by this risk

* [Clinical trial participants](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)
* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5545.md)

## Stakeholders who can mitigate this risk

* [Public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_173.md)
* [Regulatory authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1293.md)
* [Vaccine developers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3379.md)

## Technologies linked to the risk

* [Advanced testing methods](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_801.md)
* [Data analytics for adverse event monitoring](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8000.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

